跳至主要内容
临床试验/NCT01548625
NCT01548625已完成不适用

Cardiovascular Effects of Incremental Diesel Exhaust Inhalation in Middle-Aged Healthy GSTM1 Null Human Volunteers

Environmental Protection Agency (EPA)1 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2007年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
6
试验地点
1
主要终点
Vascular effects of DE exposure

研究概览

简要总结

Purpose: A growing body of epidemiological data suggests an increased risk of cardiovascular events associated with air pollutants. Reactive oxygen species (ROS) have been implicated as a potential mechanism for the adverse effects of air pollutants and genetic polymorphisms of the glutathione-s-transferases (GSTs) have been shown to participate in the antioxidant defenses to air pollutants. This study examined the dose effects of diesel exhaust exposure on the cardiovascular system in healthy middle-aged subjects.

Participants: Six healthy 50-75 year-old male and female subjects with GSTM1 null genotype had 3 sequential exposures to the diesel exhausts at concentrations approximately 100 µg/m3, 200 µg/m3, and 300 µg/m3 for 2 hours with a about 2 weeks of interval between exposures.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
50 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 50-75 years old generally healthy male and female.
  • Normal resting ECG.
  • Oxygen saturation greater than 94% at the time of physical exam.

排除标准

  • A history of angina, cardiac arrhythmias, and ischemic myocardial infarction or coronary bypass surgery.
  • Cardiac pacemaker.
  • Uncontrolled hypertension (> 150 systolic, > 90 diastolic).
  • Neurodegenerative diseases such as Parkinson's and Alzheimer disease.
  • A history of chronic illnesses such as diabetes, cancer, rheumatologic diseases, immunodeficiency state, known cardiovascular disease, chronic respiratory diseases such as chronic obstructive pulmonary disease or severe asthma.
  • History of bleeding diathesis.
  • Currently taking HMG-CoA reductase inhibitors for hyperlipidemia including lovastatin, pravastatin, simvastatin, and atorvastatin.
  • Currently taking beta-blockers to control hypertension and/or arrhythmias.
  • Use of oral anticoagulants.
  • Participants must refrain from all over-the-counter NSAIDs for a period of two weeks prior to exposure. Low-dose aspirin will be acceptable. Medications not specifically mentioned here may be reviewed by the investigators prior to a participant's inclusion in the study.
  • Subjects who are currently smoking or have smoking history within 1 year of study (defined as more than one pack of cigarettes in the past year).
  • Subject is pregnant, attempting to become pregnant or breastfeeding.
  • No exposure will be conducted within 4 weeks of a respiratory tract infection.

结局指标

主要结局

Vascular effects of DE exposure

时间窗: One hour before and 1 hour after DE exposure

Brachial artery ultrasound was performed to measure vascular effects of DE exposure

次要结局

未报告次要终点

研究者

发起方
Environmental Protection Agency (EPA)
申办方类型
Fed
责任方
Principal Investigator
主要研究者

Haiyan Tong

Principal Investigator

Environmental Protection Agency (EPA)

研究点 (1)

Loading locations...

相似试验